Importantly, in IBD patients CD39+ γδ+ LPL displayed only low ex vivo FOXP3 expression but the frequency of FOXP3+ CD39+ γδ+ LPL was significantly higher compared to healthy controls (p = 0.0221), (Supplementary Figure S6C). This evidence concerns the gene ENTPD1 and inflammatory bowel disease.